JSR Life Sciences today announced that KBI Biopharma, Inc. (KBI) and Selexis SA are consolidating as one organization under the KBI Biopharma name to accelerate innovation and growth for its global biopharma customers.
KAHR today announced positive results from the dose escalation Phase I study of DSP107 in combination with atezolizumab (anti-PD-L1) in patients with advanced solid tumors.
KalVista Pharmaceuticals, Inc. announced it will present at the Jefferies Global Healthcare Conference on Wednesday, June 7th, 2023 at 2:00 p.m. ET in New York, NY.
KalVista Pharmaceuticals to Present at Jefferies 2023 Global Healthcare Conference Read More »
NanoViricides, Inc., announces that the Company’s President, Dr. Anil Diwan, will be presenting a talk in person at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ET.
HighField Biopharmaceuticals, a clinical stage immuno-oncology company using immunoliposomes to treat cancer, announced the publication of an abstract including preliminary data from a Phase 1a clinical trial of HF1K16 in refractory metastatic cancer patients.
En este Short os hablamos de unos sonidos desconocidos que se pueden detectar en la estratosfera. …
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies, has announced the launch of Constellation™, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy Annual Meeting 2023.
Medivir AB announces that the number of shares and votes in Medivir has changed during May 2023 as a result of the previously announced share issue of 970,500 shares of series C and the reclassification of 105,750 shares of series C into ordinary shares, which was carried out as part of the long-term incentive program
Change in the number of shares and votes in Medivir AB (publ) Read More »
En un mundo cada vez más conectado, donde nuestra información personal y financiera se encuentra en línea, la seguridad de nuestras contraseñas se ha convertido en una preocupación primordial. A menudo escuchamos noticias sobre brechas de seguridad y ataques cibern …
Construyendo un muro impenetrable: Cómo crear contraseñas sólidas y seguras Read More »
Asieris Pharmaceuticals announced the phase I clinical data of ANTICIPATE Study was published for the first time at the 2023 American Society of Clinical Oncology annual meeting in Chicago.
Asieris’ progress in MIBC receives renewed attention with its inclusion in ASCO 2023 Read More »
